Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated just now
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Apoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling

  1. 1Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow 119334, Russia

Abstract

This review summarizes current knowledge on the role of human cathelicidin LL-37 in the regulation of apoptosis. LL-37 can modulate programmed cell death pathways, exerting either proapoptotic or antiapoptotic effects depending on various factors, such as cell type and peptide concentration. Data on LL-37 derivatives and their involvement in apoptosis are also discussed. Understanding the molecular mechanisms underlying LL-37 regulation of apoptosis is necessary to expand the therapeutic potential of this peptide in various pathological conditions, including cancer.

Related

  1. Diallyl trisulfide suppresses GP130-dependent signaling to induce mitotic arrest and death receptor‑dependent apoptosis in gastric cancer cells
    Jianli Li, Haiqin Ren, Liyue Zhang +6
    Food Science and BiotechnologyPeer-reviewedLicence not statedFull textPlant biologyPMC
  2. Notoginsenoside R1 modulates the ATF4-CHOP-Bcl2 signaling pathway to alleviate mitochondrial stress damage and apoptosis in asthmatic airway epithelial cells
    Yaozheng Ling, Ling Guan, Yu Zhao +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  3. Harnessing marine polysaccharides for breast cancer therapy: ulvan synergizes with nano-selenium to induce programmed cell death through dual modulation of autophagy and apoptosis
    Sara A. Mekkawy, Ahmed M. Abdelmaguid, Manal F. El-Khadragy +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textEcologyCrossrefEurope PMCPMC
  4. Apoptosis-inducing potential of the hexane fraction of Cassia fistula L. against MCF-7 cells via apoptosis signaling pathways.
    Iftikhar Ahmad, Ehab M M Ali, Torki A Zughaibi +5
    Biochemistry and biophysics reportsPeer-reviewedCC BY-NC-NDFull textPlant biologyEurope PMC
  5. Chronic Glyphosate Exposure Induces Spleen Injury via ROS-Mitochondrial Pathway, Accompanied by Changes in Inflammation and Apoptosis Related to RHOA / ROCK Pathway.
    Yinghua Ma, Zhiyao Liu, Zifa Li +11
    Drug design, development and therapyPeer-reviewedCC BY-NCFull textPlant biologyEurope PMCPMC
BibTeX
@article{voronko2026apoptosis,
  title = {{Apoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling}},
  author = {Olga Evgenevna Voronko and Vitalia Sergeevna Novikova and Olesya Olegovna Klychkova and Margarita Pavlovna Markina and Arthur Anatolievich Lee and Dmitry Alexandrovich Kashirskikh and Victoria Alexandrovna Khotina and Vagif Ali oglu Gasanov},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = sep,
  doi = {10.3390/ijms27188351},
  url = {https://www.mdpi.com/1422-0067/27/18/8351},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Apoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling
AU  - Olga Evgenevna Voronko
AU  - Vitalia Sergeevna Novikova
AU  - Olesya Olegovna Klychkova
AU  - Margarita Pavlovna Markina
AU  - Arthur Anatolievich Lee
AU  - Dmitry Alexandrovich Kashirskikh
AU  - Victoria Alexandrovna Khotina
AU  - Vagif Ali oglu Gasanov
PY  - 2026
DA  - 2026/09/19
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27188351
UR  - https://www.mdpi.com/1422-0067/27/18/8351
AB  - This review summarizes current knowledge on the role of human cathelicidin LL-37 in the regulation of apoptosis. LL-37 can modulate programmed cell death pathways, exerting either proapoptotic or antiapoptotic effects depending on various factors, such as cell type and peptide concentration. Data on LL-37 derivatives and their involvement in apoptosis are also discussed. Understanding the molecular mechanisms underlying LL-37 regulation of apoptosis is necessary to expand the therapeutic potential of this peptide in various pathological conditions, including cancer.
SN  - 1422-0067
ER  -